Markus Zeitlinger

Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans.

Aiman Abrahim, Martin Brunner, Oliver Langer, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Assessment of Regional Differences in Tariquidar-Induced P-Glycoprotein Modulation at the Human Blood–Brain Barrier

Friederike Neumann, Wolfgang Löscher, Oliver Langer, 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled Verapamil

Aiman Abrahim, Oliver Langer, Rudolf Karch, 2011, Clinical pharmacokinetics.

[Clinico-pharmacologic explanation models of cerivastatin associated rhabdomyolysis].

Markus Müller, Markus Zeitlinger, 2003, Wiener medizinische Wochenschrift.

Clinical Applications of Levofloxacin for Severe Infections

Wolfgang Graninger, Markus Zeitlinger, 2004, Chemotherapy.

A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-11C-Verapamil and PET

Stephan Kopp, Peter Chiba, Wolfgang Löscher, 2009, Journal of Nuclear Medicine.

Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET

Friederike Neumann, Aiman Abrahim, Oliver Langer, 2009, European Journal of Clinical Pharmacology.